Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0857020040190010226
Kosin Medical Journal
2004 Volume.19 No. 1 p.226 ~ p.231
Combination Therapy of Fluoride and Low Dose Estrogen in Postmenopausal Osteopenia
Kim Ghi-Chan

Jeong Ho-Joong
Shin Jeong-Beom
Chung Suk-Mo
Abstract
Background : To investigate the changes of BMD, biochemical bone markers and lipid profiles after combination therapy of Fluoride and low dose estrogen(0.3§·) in postmenopausal osteopenia.

Materials and Method : We studied 70 women with postmenopausal osteopenia who visited at Department of rehabilitation medicine, Kosin Medical Center from march 2002 to may 2003. Subjects were divided in two groups : Gorup ¥°(n=30), treated with Fluocalcic^(?) (monofluorophosphate 100§·+Calcium 500§·), calcium(500§·) and low dose estrogen, and Group ¥±(n=40), treated with estrogen(0.625§·) and calcium (1.0g). BMD at the L-spine and femur, osteocalcin, deoxypyridinoline, and lipid profiles were measured at baseline and 1 year after treatment.

Result : 1) Average postmenopausal periods are 2.90yrs and 3.53yrs each other. 2) BMD increased significantly in two groups, and BMD in group I increased significantly more than that in group¥±. 3) Deoxypyridinoline decreased significantly in group ¥°, but decreased significantly in group ¥±. 4) Total cholesterol and LDL cholestero; decreased significantly in two groups, and no significant difference between two groups.

Conclusion : We concluded that combination therapy with fluocalcic^(?), calcium and low dose estrogen in postmenopausal osteopenia was more effective than combination therapy with estrogen and calcium to prevent postmenopausal osteoporosis.
KEYWORD
Postmenopausal osteopenia, Fluoride, Low dose estrogen, BMD
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)